Canadians with primary biliary cholangitis one step closer to treatment as Gilead reaches national agreement for Lyvdelzi
GILD•Gilead reached an agreement for public reimbursement of Lyvdelzi (seladelpar) in Canada. Reimbursement could begin as early as 2027.
1. Canadian reimbursement agreement
Gilead reached a national agreement for public reimbursement of Lyvdelzi (seladelpar) in Canada. Reimbursement could begin as early as 2027.
